The key list
Powered by
Leading global companies by R&D expenditure
This month our new pharma key list brings you the 15 largest companies globally by R&D expenditure as ranked by GlobalData's Pharmaceuticals Intelligence Centre. All numbers as of November 2019.
Company name | Annual revenue ($million) | Headquarters location |
F. Hoffmann-La Roche Ltd | 11,294 | Switzerland |
Johnson & Johnson | 10,775 | USA |
AbbVie Inc | 10,329 | USA |
Merck & Co Inc | 9,600 | USA |
Novartis AG | 8,681 | Switzerland |
Pfizer Inc | 8,006 | USA |
Sanofi | 6,951 | France |
Bayer AG | 6,191 | Germany |
Celgene Corp | 5,673 | USA |
Eli Lilly and Co | 5,307 | USA |
AstraZeneca Plc | 5,266 | UK |
Bristol-Myers Squibb Co | 5,052 | USA |
GlaxoSmithKline Plc | 4,969 | UK |
Gilead Sciences Inc | 4,846 | USA |
Amgen Inc | 3,737 | USA |